JP2005097319A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005097319A5 JP2005097319A5 JP2004347900A JP2004347900A JP2005097319A5 JP 2005097319 A5 JP2005097319 A5 JP 2005097319A5 JP 2004347900 A JP2004347900 A JP 2004347900A JP 2004347900 A JP2004347900 A JP 2004347900A JP 2005097319 A5 JP2005097319 A5 JP 2005097319A5
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US6169993A | 1993-05-12 | 1993-05-12 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP6525508A Division JPH08510240A (ja) | 1993-05-12 | 1994-05-03 | Ｃ型肝炎ウイルスｅ２／ｎｓ１領域の保存モチーフ |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2005097319A JP2005097319A (ja) | 2005-04-14 |
| JP2005097319A5 true JP2005097319A5 (enExample) | 2005-11-04 |
Family
ID=22037528
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP6525508A Pending JPH08510240A (ja) | 1993-05-12 | 1994-05-03 | Ｃ型肝炎ウイルスｅ２／ｎｓ１領域の保存モチーフ |
| JP2004347900A Withdrawn JP2005097319A (ja) | 1993-05-12 | 2004-11-30 | Ｃ型肝炎ウイルスｅ２／ｎｓ１領域の保存モチーフ |
| JP2005152406A Withdrawn JP2005325126A (ja) | 1993-05-12 | 2005-05-25 | Ｃ型肝炎ウイルスｅ２／ｎｓ１領域の保存モチーフ |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP6525508A Pending JPH08510240A (ja) | 1993-05-12 | 1994-05-03 | Ｃ型肝炎ウイルスｅ２／ｎｓ１領域の保存モチーフ |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2005152406A Withdrawn JP2005325126A (ja) | 1993-05-12 | 2005-05-25 | Ｃ型肝炎ウイルスｅ２／ｎｓ１領域の保存モチーフ |
Country Status (7)
| Country | Link |
|---|---|
| US (6) | US6692907B1 (enExample) |
| EP (2) | EP0697888B1 (enExample) |
| JP (3) | JPH08510240A (enExample) |
| AT (1) | ATE249838T1 (enExample) |
| CA (1) | CA2162557C (enExample) |
| DE (1) | DE69433160T2 (enExample) |
| WO (1) | WO1994026306A1 (enExample) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0697888B1 (en) * | 1993-05-12 | 2003-09-17 | Chiron Corporation | Conserved motif of hepatitis c virus e2/ns1 region |
| DE19504302A1 (de) * | 1995-02-09 | 1996-08-14 | Boehringer Mannheim Gmbh | Methode zur serologischen Typisierung mittels typspezifischer Antigene |
| US6110465A (en) * | 1995-06-07 | 2000-08-29 | The United States Of America As Represented By The Department Of Health And Human Services | Nucleotide and deduced amino acid sequences of hypervariable region 1 of the envelope 2 gene of isolates of hepatitis C virus and the use of reagents derived from these hypervariable sequences in diagnostic methods and vaccines |
| KR970065713A (ko) * | 1996-03-19 | 1997-10-13 | 성재갑 | C형 간염 바이러스(일본형)의 분비형 외피 단백질 1 및 2 |
| GB9810756D0 (en) | 1998-05-19 | 1998-07-15 | Angeletti P Ist Richerche Bio | Mimotopes of hypervariable region 1 of the e2 glycoprotein of hcv and uses thereof |
| AU7602800A (en) * | 1999-09-23 | 2001-04-24 | Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The | Hepatitis c virus envelope two protein (e2) which lacks all or part of the hypervariable region one (hvr1), corresponding nucleic acids, chimeric viruses and uses thereof |
| EP1239876B1 (en) * | 1999-11-19 | 2008-07-30 | Csl Limited | Hcv vaccine compositions |
| WO2001058459A1 (fr) * | 2000-02-14 | 2001-08-16 | Mitsubishi Pharma Corporation | Remedes contre l'hepatite c |
| US20110097332A1 (en) * | 2007-08-06 | 2011-04-28 | Martina Buck | Composition and Method of Use for HCV Immunization |
| US8314371B2 (en) | 2008-11-06 | 2012-11-20 | Applied Materials, Inc. | Rapid thermal processing chamber with micro-positioning system |
| US20100322943A1 (en) | 2009-06-17 | 2010-12-23 | Thomas Cantor | Therapeutic and diagnostic affinity purified specific polyclonal antibodies |
| FR2984328B1 (fr) | 2011-12-20 | 2016-12-30 | Bio-Rad Innovations | Procede de detection d'une infection par le virus de l'hepatite c |
| GB201415714D0 (en) * | 2014-09-05 | 2014-10-22 | Medical Res Council | Antibodies and antigen binding fragments thereof |
Family Cites Families (39)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6146633A (en) * | 1973-05-07 | 2000-11-14 | The Ohio State University | Method for treatment of antigenically modified polypeptides |
| US4491632A (en) | 1979-10-22 | 1985-01-01 | The Massachusetts General Hospital | Process for producing antibodies to hepatitis virus and cell lines therefor |
| US4444887A (en) | 1979-12-10 | 1984-04-24 | Sloan-Kettering Institute | Process for making human antibody producing B-lymphocytes |
| CA1188985A (en) * | 1980-07-01 | 1985-06-18 | Edward J. Stott | Production of viral antigens |
| DE3167442D1 (en) | 1980-07-07 | 1985-01-10 | Nat Res Dev | Improvements in or relating to cell lines |
| US4341761A (en) | 1980-07-25 | 1982-07-27 | E. I. Du Pont De Nemours And Company | Antibodies to immunogenic peptides and their use to purify human fibroblast interferon |
| US4466917A (en) | 1981-02-12 | 1984-08-21 | New York University | Malaria vaccine |
| US4493890A (en) | 1981-03-23 | 1985-01-15 | Miles Laboratories, Inc. | Activated apoglucose oxidase and its use in specific binding assays |
| US4399121A (en) | 1981-11-04 | 1983-08-16 | Miles Laboratories, Inc. | Iodothyronine immunogens and antibodies |
| US4427783A (en) | 1981-12-14 | 1984-01-24 | Hoffmann-La Roche Inc. | Immunoassay of thymosin α1 |
| EP0116201B1 (en) | 1983-01-12 | 1992-04-22 | Chiron Corporation | Secretory expression in eukaryotes |
| CA1341302C (en) | 1983-02-22 | 2001-10-09 | Rae Lyn Burke | Yeast expression systems with vectors having gapdh or pyk promoters and synthesis of foreign protein |
| GB8308235D0 (en) | 1983-03-25 | 1983-05-05 | Celltech Ltd | Polypeptides |
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| EP0164556B1 (en) | 1984-05-11 | 1994-03-02 | Chiron Corporation | Enhanced yeast transcription employing hybrid promoter region constructs |
| US4722840A (en) | 1984-09-12 | 1988-02-02 | Chiron Corporation | Hybrid particle immunogens |
| US4683195A (en) | 1986-01-30 | 1987-07-28 | Cetus Corporation | Process for amplifying, detecting, and/or-cloning nucleic acid sequences |
| US4683202A (en) | 1985-03-28 | 1987-07-28 | Cetus Corporation | Process for amplifying nucleic acid sequences |
| US4629783A (en) | 1985-04-29 | 1986-12-16 | Genetic Systems Corporation | Synthetic antigen for the detection of AIDS-related disease |
| CA1319101C (en) | 1986-09-03 | 1993-06-15 | Marta Iris Sabara | Rotavirus nucleocapsid protein with or without binding peptides as immunologic carriers for macromolecules |
| CN1074422C (zh) | 1987-11-18 | 2001-11-07 | 希龙股份有限公司 | 制备含有hcv表位的分离多肽的方法 |
| US5252459A (en) | 1988-09-23 | 1993-10-12 | Abbott Laboratories | Indicator reagents, diagnostic assays and test kits employing organic polymer latex particles |
| HUT54896A (en) * | 1989-03-17 | 1991-04-29 | Chiron Corp | Process for producing aquous diagnosticum and vaccine of nanbv |
| HUT59964A (en) | 1989-05-18 | 1992-07-28 | Chiron Corp | Process for producing new nanbv diagnostica for determining hepatitis c virus |
| HU212924B (en) | 1989-05-25 | 1996-12-30 | Chiron Corp | Adjuvant formulation comprising a submicron oil droplet emulsion |
| US5308750A (en) * | 1989-12-22 | 1994-05-03 | Abbott Laboratories | Monoclonal antibodies to putative HCV E2/NS1 proteins and methods for using same |
| US5747239A (en) * | 1990-02-16 | 1998-05-05 | United Biomedical, Inc. | Synthetic peptides specific for the detection of antibodies to HCV, diagnosis of HCV infection and preventions thereof as vaccines |
| CA2047792C (en) | 1990-07-26 | 2002-07-02 | Chang Y. Wang | Synthetic peptides specific for the detection of antibodies to hcv, diagnosis of hcv infection and prevention thereof as vaccines |
| US6274148B1 (en) | 1990-11-08 | 2001-08-14 | Chiron Corporation | Hepatitis C virus asialoglycoproteins |
| EP0842947B2 (en) * | 1990-11-08 | 2009-03-18 | Novartis Vaccines and Diagnostics, Inc. | Hepatitis C virus asialoglycoproteins |
| US5574132A (en) | 1991-04-05 | 1996-11-12 | Biochem Immunosystems Inc. | Peptides and mixtures thereof for detecting antibodies to hepatitis C virus (HCV) |
| WO1993000365A2 (en) | 1991-06-24 | 1993-01-07 | Chiron Corporation | Hepatitis c virus (hcv) polypeptides |
| WO1993006126A1 (en) * | 1991-09-13 | 1993-04-01 | Chiron Corporation | Immunoreactive hepatitis c virus polypeptide compositions |
| EP0583481B1 (en) | 1992-02-05 | 1999-11-10 | Daikin Industries, Ltd. | Polytetrafluoroethylene powder for molding |
| US5891640A (en) | 1992-03-06 | 1999-04-06 | N.V. Innogenetics S.A. | Peptide derived from human immunodeficiency virus type 1 (HIV-1), isolate ant70, containing an immunodominant epitope and it's use in immunodiagnostic assays |
| EP0697888B1 (en) * | 1993-05-12 | 2003-09-17 | Chiron Corporation | Conserved motif of hepatitis c virus e2/ns1 region |
| EP0992580B1 (en) | 1993-11-04 | 2005-03-09 | Innogenetics N.V. | Immunodominant human T-cell epitopes of Hepatitis C virus |
| US5709995A (en) | 1994-03-17 | 1998-01-20 | The Scripps Research Institute | Hepatitis C virus-derived peptides capable of inducing cytotoxic T lymphocyte responses |
| MXPA02012401A (es) * | 2000-06-15 | 2003-04-25 | Chiron Corp | Inmunoensayos para anticuerpos anti-virus de hepatitis c. |
-
1994
- 1994-05-03 EP EP94915985A patent/EP0697888B1/en not_active Revoked
- 1994-05-03 WO PCT/US1994/004853 patent/WO1994026306A1/en not_active Ceased
- 1994-05-03 EP EP03077917A patent/EP1421951A3/en not_active Withdrawn
- 1994-05-03 DE DE69433160T patent/DE69433160T2/de not_active Revoked
- 1994-05-03 CA CA002162557A patent/CA2162557C/en not_active Expired - Fee Related
- 1994-05-03 AT AT94915985T patent/ATE249838T1/de not_active IP Right Cessation
- 1994-05-03 JP JP6525508A patent/JPH08510240A/ja active Pending
-
1995
- 1995-05-09 US US08/437,943 patent/US6692907B1/en not_active Expired - Lifetime
- 1995-05-09 US US08/437,952 patent/US7098303B1/en not_active Expired - Lifetime
- 1995-05-09 US US08/438,182 patent/US20030017156A1/en not_active Abandoned
- 1995-05-09 US US08/438,183 patent/US7135185B1/en not_active Expired - Lifetime
-
1997
- 1997-03-25 US US08/823,980 patent/US7252827B1/en not_active Expired - Fee Related
-
2004
- 2004-11-30 JP JP2004347900A patent/JP2005097319A/ja not_active Withdrawn
-
2005
- 2005-05-25 JP JP2005152406A patent/JP2005325126A/ja not_active Withdrawn
-
2006
- 2006-09-18 US US11/522,614 patent/US7371386B2/en not_active Expired - Fee Related